Gene Discovery News: Breaking Gene Discovery News, Comments and Articles. - Page: 5

07:56 EDT 27th March 2015 | BioPortfolio

Gene Discovery News - Page: 5RSS

Read the latest Gene Discovery News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on Gene Discovery.

Search or Follow Our Gene Discovery - Page: 5 News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More Gene Discovery - Page: 5 News.

Showing "gene discovery" News Articles 101 to 125 of 7,000+

Wednesday 25th March 2015

GSK Seeks Early Drug Discovery Partnerships with Academics in Europe, Canada, and U.S.

GSK is encouraging academic scientists in Europe, Canada and the US to submit their novel early drug discovery research proposals into its third annual Discovery Fast Track Challenge – a program designed to accelerate the translation of early-stage research into game-changing new medicines. The challenge provides a new template for drug discovery as it seeks to rapidly uncover the best opportuni...

Songs To Educate Delights Young Students in Arts Integrated "Human Body School" Performing Arts Program

(PRWEB) March 25, 2015 Talking Hands Talking Feet, the teaching artistry of Songs To Educate says, "Inner Space...is the Final Frontier". Understanding human body mechanics is one thing. Understanding the organic intelligence implicit ...

BMS takes on Novo Nordisk's autoimmune projects

Bristol-Myers Squibb (BMS) has boosted its position in immunology research by licensing a portfolio of autoimmune disease therapies from Denmark's Novo Nordisk.The Danish drugmaker indicated last year that it intended to narrow its R&D to focus m...

Vectalys – lentiviral vectors

Vectalys is a biotech company specialized in gene delivery through high quality lentiviral vectors production and providing full services (from expression system design to animal model creation). Vectalys – lentiviral vectors Transferring target genes into functional cells allow the development … Continue reading → Cet article Vectalys – lentiviral vectors est apparu en pre...

Rosetta Genomics to Launch Next-Generation Sequencing Panel from Admera Health

OncoGxOne™ leverages Admera Health’s industry-leading, next-generation sequencing technology Will provide oncologists with unique solution of cutting-edge comprehensive genomic profiling and microRNA profiling to optimize therapeutic decision-making Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-b...

Gene Upshaw Memorial Tahoe Forest Cancer Center Awarded for Excellence in Lung Cancer Care

Bonnie J. Addario Lung Cancer Foundation Honors Gene Upshaw Memorial Tahoe Forest Cancer Center in Truckee with Community Hospital Center of Excellence Award Today the Bonnie J. Addario Lung Cancer Foundation (ALCF) awarded Gene Upshaw Memorial Tahoe Forest Cancer Center of Truckee, California, the official designation as a Community Hospital Center of...

Federal Investment in Neuroscience and Neurotechnology Hearing on Thursday, March 26

WASHINGTON, March 25, 2015 /PRNewswire-USNewswire/ -- The House Appropriations Subcommittee on Commerce, Justice, and Science (CJS) will hold a hearing on federal investments in neuroscience and neurotechnology this Thursday, March 26 at 10:30am in Room H-309 in the Capitol. Led by Congressman Chaka Fattah (PA-02), lead Democrat on the Subcommittee, the hearing will examine the feder...

Seeking Early-Stage Academic Research for Tomorrow’s New Medicine

SOURCE: GSK DESCRIPTION:Do you have an idea that you think could become the next breakthrough medicine?  If so, we want to hear from you! Today kicks off our third annual Discovery Fast Track Challenge – a program designed to accelerate the translation of early-stage research into game-changing new medicines. The challenge is open to academic scientists in the US, Canada, and Europe who wan...

What Angelina Jolie's Very Personal Medicine Tells Us About Personalized Medicine

Angelina Jolie told the story yesterday of her decision to have her ovaries and fallopian tubes surgically removed to reduce the risk of ovarian cancer due to the faulty BRCA1 gene she was born with. This follows a similar decision to undergo a doubl...

GSK s 2015 Discovery Fast Track Challenge seeks early drug discovery partnerships

With academics in Europe, Canada and the US

Therapure Innovations Receives FDA Approval to Proceed with a Phase 1 Clinical Trial of the Targeted Liver Cancer Therapeutic TBI 302

Therapure Innovations, a division of Therapure Biopharma Inc., today announces that the U.S. Food and Drug Administration (FDA) has given the company approval to proceed with a Phase 1 clinical trial of TBI 302, a targeted therapeutic for the treatment of liver cancer. TBI 302 is the first drug to emerge from Therapure’s targeted drug delivery p...

Transcelerate Status Report

Here's a followup to something I wrote in 2012. That was when a joint venture called Trancelerate was announced to address precompetitive drug development issues, clinical trial design, and so on. Someone asked me the other day what had come out of ...

Agena Bioscience Launches LungFUSION™ Panel for Rapid Identification of ALK, RET, and ROS1 Translocations in NSCLC Tumors

SAN DIEGO, March 25, 2015 /PRNewswire/ -- Agena Bioscience today released the LungFUSION Panel for rapid and sensitive identification of oncogenic ALK, RET, and ROS1 gene fusions in non-small cell lung cancer tumors.   Using as little as 10 ng of cDNA template, the research use only, single-well panel identifies expressed translocations of known clinical relevance in FFPE and fresh frozen ...

Celladon Heart-Failure Study Looms Large as Next Big Test for Gene Therapy

Click to view a price quote on CLDN. Click to research the Drugs industry.

Leukemia like Achilles, has its own weakness

Leukemia cells from patients suffering from chronic myeloid leukemia, especially in the advanced stage, lack one of the proteins: the famous BRCA1. Importantly, the protein is not present even if the patient carries the proper, not mutated gene respo...

Genethon - Product Pipeline Review - 2015

Recently added to the BioPortfolio report store, Genethon - Product Pipeline Review - 2015 is a new report from Global Markets Direct published on 2015-02-23. This 34-page report is available in PDF from $1500. Genethon - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘Genethon - Product Pipeline Review - 2015’, provides an overview of the Genethon’s pharmaceutical resea...

Alpha- Antitrypsin Deficiency - Pipeline Review, H1 2015

Recently added to the BioPortfolio report store, Alpha- Antitrypsin Deficiency - Pipeline Review, H1 2015 is a new report from Global Markets Direct published on 2015-02-23. This 81-page report is available in PDF from $2000. Alpha- Antitrypsin Deficiency - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Alpha- Antitrypsin Deficiency - Pipeline Review, H1 2015’, provides an over...

Thalassemia - Pipeline Review, H1 2015

Recently added to the BioPortfolio report store, Thalassemia - Pipeline Review, H1 2015 is a new report from Global Markets Direct published on 2015-02-23. This 100-page report is available in PDF from $2000. Thalassemia - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Thalassemia - Pipeline Review, H1 2015’, provides an overview of the Thalassemia’s therapeutic pipeline. Thi...

Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection - Pipeline Review, H1 2015

Recently added to the BioPortfolio report store, Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection - Pipeline Review, H1 2015 is a new report from Global Markets Direct published on 2015-02-23. This 62-page report is available in PDF from $2000. Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Severe Acut...

Myocardial Ischemia - Pipeline Review, H1 2015

Recently added to the BioPortfolio report store, Myocardial Ischemia - Pipeline Review, H1 2015 is a new report from Global Markets Direct published on 2015-02-23. This 82-page report is available in PDF from $2000. Myocardial Ischemia - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Myocardial Ischemia - Pipeline Review, H1 2015’, provides an overview of the Myocardial Ischemi...

Lycera Announces Milestone in Merck Collaboration

NEW YORK and ANN ARBOR, Mich., March 25, 2015 /PRNewswire/ -- Lycera Corp., a biopharmaceutical company developing breakthrough medicines to treat cancer and autoimmune disease, today announced the achievement of a milestone under the Company's collaboration agreement with Merck, known as MSD outside the United States and Canada, triggering an undisclosed payment.  The program, announce...

Regulus Receives Orphan Medicinal Product Designation from the European Commission for RG-012, a microRNA Therapeutic in Development for the Treatment of Alport Syndrome

LA JOLLA, Calif., March 25, 2015 /PRNewswire/ -- Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, announced today that the European Commission has granted orphan medicinal product designation for RG-012, a single stranded, chemically modified oligonucleotide that binds to and inhibits the fu...

Lexicon Pharmaceuticals Announces First Patient Screened In Pivotal Phase 3 Clinical Trial Of Sotagliflozin

THE WOODLANDS, Texas, March 25, 2015 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on developing breakthrough treatments for human disease, today announced that it has commenced screening in its first pivotal Phase 3 clinical trial of sotagliflozin for type 1 diabetes.  "We are pleased to achieve this important milestone in sotagliflo...

Signum Dermalogix Out-Licenses SIG990 to Dermata Therapeutics for Topical Treatment of Rosacea

PRINCETON, N.J., March 25, 2015 /PRNewswire/ -- Signum Dermalogix, Inc., ("Dermalogix"), a biotechnology company focused on the discovery and development of innovative compounds and products in the field of dermatology, has entered into an agreement with Dermata Therapeutics ("Dermata") to develop a topical product for the treatment of patients with rosacea. SIG990 is a novel, first-in-class ...

Gene regulates healing process after myocardial infarction

In the wake of a myocardial infarction, parts of the myocardium die and are replaced by scar tissue. The formation and stability of scar tissue is key to the survival of patients following an acute myocardial infarction. Scientists at the Max Planck ...


Search BioPortfolio:
Loading
Advertisement
Advertisement

News Quicklinks